| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Matteo Forloni | Q56670648 |
| P2093 | author name string | Narendra Wajapeyee | |
| Paul M Lizardi | |||
| P2860 | cites work | Transcriptional Regulatory Elements in the Human Genome | Q22065387 |
| A large-scale RNAi screen in human cells identifies new components of the p53 pathway | Q24319883 | ||
| Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes | Q24540025 | ||
| Frequent mutation of BAP1 in metastasizing uveal melanomas | Q24601069 | ||
| Core signaling pathways in human pancreatic cancers revealed by global genomic analyses | Q24606006 | ||
| Cap analysis gene expression for high-throughput analysis of transcriptional starting point and identification of promoter usage | Q24616834 | ||
| A comprehensive catalogue of somatic mutations from a human cancer genome | Q24628532 | ||
| Recurring mutations found by sequencing an acute myeloid leukemia genome | Q24634204 | ||
| DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome | Q24644436 | ||
| A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene | Q24647664 | ||
| Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1 | Q24651548 | ||
| Comprehensive genomic characterization defines human glioblastoma genes and core pathways | Q24656128 | ||
| Pyruvate kinase M2 is a phosphotyrosine-binding protein | Q27650067 | ||
| Sequencing technologies - the next generation | Q27860568 | ||
| Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans | Q27860867 | ||
| Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells | Q27860926 | ||
| PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer | Q27860985 | ||
| Structural basis for tumor pyruvate kinase M2 allosteric regulation and catalysis | Q28119086 | ||
| Lessons from hereditary colorectal cancer | Q28131788 | ||
| Comprehensive mapping of long-range interactions reveals folding principles of the human genome | Q28131819 | ||
| Capturing chromosome conformation | Q28201750 | ||
| Post-transcriptional gene silencing by double-stranded RNA | Q28205087 | ||
| Pyruvate kinase type M2 and its role in tumor growth and spreading | Q28252131 | ||
| The concept of synthetic lethality in the context of anticancer therapy | Q28268061 | ||
| Second-generation shRNA libraries covering the mouse and human genomes | Q28275183 | ||
| The cancer epigenome--components and functional correlates | Q28278109 | ||
| The epigenomics of cancer | Q28289975 | ||
| Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma | Q28292742 | ||
| Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged | Q28297381 | ||
| p53 mutations in human cancers | Q28302973 | ||
| An oestrogen-receptor-α-bound human chromatin interactome | Q29541719 | ||
| The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth | Q29547680 | ||
| A global view of gene activity and alternative splicing by deep sequencing of the human transcriptome | Q29615877 | ||
| Genome-wide analysis of mammalian promoter architecture and evolution | Q29616717 | ||
| Principles of cancer therapy: oncogene and non-oncogene addiction | Q29616779 | ||
| Integrative genomic profiling of human prostate cancer | Q29619905 | ||
| Genome-wide in situ exon capture for selective resequencing | Q30004193 | ||
| Advances in understanding cancer genomes through second-generation sequencing | Q30014827 | ||
| Massively parallel exon capture and library-free resequencing across 16 genomes | Q30860233 | ||
| Genome wide identification and classification of alternative splicing based on EST data | Q30926705 | ||
| Increasing alternative promoter repertories is positively associated with differential expression and disease susceptibility | Q30979181 | ||
| A resource for large-scale RNA-interference-based screens in mammals. | Q33200135 | ||
| CAGE: cap analysis of gene expression | Q33234345 | ||
| Lessons from Nature: microRNA-based shRNA libraries | Q33255058 | ||
| Integrative genomic approaches identify IKBKE as a breast cancer oncogene | Q33287979 | ||
| Cancer proliferation gene discovery through functional genomics. | Q33317743 | ||
| Genome-wide analysis of alternative promoters of human genes using a custom promoter tiling array | Q33355172 | ||
| Methods for analyzing deep sequencing expression data: constructing the human and mouse promoterome with deepCAGE data | Q33485579 | ||
| Loss of IGF2 imprinting is associated with abrogation of long-range intrachromosomal interactions in human cancer cells | Q33630697 | ||
| Making sense of cancer genomic data | Q33846850 | ||
| A genome-wide RNA interference screen reveals an essential CREB3L2-ATF5-MCL1 survival pathway in malignant glioma with therapeutic implications | Q33900952 | ||
| Target-enrichment strategies for next-generation sequencing | Q34095491 | ||
| The mutation spectrum revealed by paired genome sequences from a lung cancer patient | Q34117627 | ||
| Genome-wide mapping of RNA Pol-II promoter usage in mouse tissues by ChIP-seq. | Q34138138 | ||
| An oncogenomics-based in vivo RNAi screen identifies tumor suppressors in liver cancer | Q34345765 | ||
| A global view of genomic information--moving beyond the gene and the master regulator | Q35014896 | ||
| Genome-wide mapping and analysis of active promoters in mouse embryonic stem cells and adult organs | Q36259297 | ||
| Mammalian RNA polymerase II core promoters: insights from genome-wide studies | Q36814333 | ||
| High-resolution mapping of copy-number alterations with massively parallel sequencing | Q37072451 | ||
| The functional consequences of alternative promoter use in mammalian genomes | Q37105466 | ||
| The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer | Q37390854 | ||
| Epigenetic silencing of the RASSF1A tumor suppressor gene through HOXB3-mediated induction of DNMT3B expression | Q37419612 | ||
| Rapid creation and quantitative monitoring of high coverage shRNA libraries | Q37440284 | ||
| Alternative promoters in developmental gene expression | Q38186018 | ||
| Integrating genetic approaches into the discovery of anticancer drugs | Q38555487 | ||
| Prediction of alternative isoforms from exon expression levels in RNA-Seq experiments | Q39740593 | ||
| Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cells | Q39843809 | ||
| A genome-wide shRNA screen identifies GAS1 as a novel melanoma metastasis suppressor gene | Q39921794 | ||
| Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7. | Q40014237 | ||
| Profiling essential genes in human mammary cells by multiplex RNAi screening | Q40018285 | ||
| An elaborate pathway required for Ras-mediated epigenetic silencing | Q40062561 | ||
| Regulation of gene expression by alternative promoters | Q40996777 | ||
| Characterization and predictive discovery of evolutionarily conserved mammalian alternative promoters | Q42277431 | ||
| Predicting the future for people with lung cancer | Q42878612 | ||
| p53: a frequent target for genetic abnormalities in lung cancer. | Q52486321 | ||
| Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma. | Q52904089 | ||
| Social and Economic Factors in the Choice of Lung Cancer Treatment | Q59188077 | ||
| P433 | issue | 11 | |
| P921 | main subject | gene discovery | Q129262352 |
| P304 | page(s) | 558-568 | |
| P577 | publication date | 2011-07-13 | |
| P1433 | published in | Trends in Biotechnology | Q2451465 |
| P1476 | title | Genome-wide approaches for cancer gene discovery | |
| P478 | volume | 29 |
| Q53211105 | Alternative splicing within the Wnt signaling pathway: role in cancer development. |
| Q42321079 | Clinical, molecular- and cytogenetic analysis of a case of severe radio-sensitivity |
| Q39070689 | Identification and characterization of human MIBP1 gene in glioma cell differentiation |
| Q31096031 | Identification of novel direct targets of Drosophila Sine oculis and Eyes absent by integration of genome-wide data sets |
| Q48938509 | Large-Scale RNA Interference Screening to Identify Transcriptional Regulators of a Tumor Suppressor Gene |
| Q64069891 | Matrix Metalloproteinase 11 Is a Potential Therapeutic Target in Lung Adenocarcinoma |
| Q38958932 | Mislocalization-related disease gene discovery using gene expression based computational protein localization prediction |
| Q35671355 | Multiple signatures of a disease in potential biomarker space: Getting the signatures consensus and identification of novel biomarkers |
| Q40467056 | The epigenetic landscape of Alu repeats delineates the structural and functional genomic architecture of colon cancer cells. |
| Q50356845 | Transcriptional Analysis-Based Integrative Genomics Approach to Identify Tumor-Promoting Metabolic Genes |
Search more.